Agiliti price target lowered to $20 from $21 at Citi

Citi analyst Jason Cassorla lowered the firm’s price target on Agiliti to $20 from $21 and keeps a Buy rating on the shares following the Q4 results. The analyst says strength in clinical engineering more than offset the decline in on-site managed services. The firm believes sentiment will improve as Agiliti laps first half of 2023 headwinds and the optics of its growth engine "comes to fruition."